Cargando…
_version_ 1784821579280023552
author Rusconi, Chiara
Ricci, Francesca
Zilioli, Vittorio R.
Marasco, Vincenzo
Calabretta, Eleonora
Guidetti, Anna
Muzi, Cristina
Mazzon, Federico
Smania, Margherita
Sollini, Martina
Meli, Erika
Rodari, Marcello
Ravano, Emanuele
Cairoli, Roberto
Corradini, Paolo
Santoro, Armando
author_facet Rusconi, Chiara
Ricci, Francesca
Zilioli, Vittorio R.
Marasco, Vincenzo
Calabretta, Eleonora
Guidetti, Anna
Muzi, Cristina
Mazzon, Federico
Smania, Margherita
Sollini, Martina
Meli, Erika
Rodari, Marcello
Ravano, Emanuele
Cairoli, Roberto
Corradini, Paolo
Santoro, Armando
author_sort Rusconi, Chiara
collection PubMed
description
format Online
Article
Text
id pubmed-9621534
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96215342022-11-01 P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles Rusconi, Chiara Ricci, Francesca Zilioli, Vittorio R. Marasco, Vincenzo Calabretta, Eleonora Guidetti, Anna Muzi, Cristina Mazzon, Federico Smania, Margherita Sollini, Martina Meli, Erika Rodari, Marcello Ravano, Emanuele Cairoli, Roberto Corradini, Paolo Santoro, Armando Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621534/ http://dx.doi.org/10.1097/01.HS9.0000890988.85828.9b Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Relapsed/Refractory
Rusconi, Chiara
Ricci, Francesca
Zilioli, Vittorio R.
Marasco, Vincenzo
Calabretta, Eleonora
Guidetti, Anna
Muzi, Cristina
Mazzon, Federico
Smania, Margherita
Sollini, Martina
Meli, Erika
Rodari, Marcello
Ravano, Emanuele
Cairoli, Roberto
Corradini, Paolo
Santoro, Armando
P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
title P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
title_full P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
title_fullStr P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
title_full_unstemmed P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
title_short P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
title_sort p105: decisional role of interim pet in relapsed/refractory classical hodgkin lymphoma treated with four begev cycles
topic Relapsed/Refractory
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621534/
http://dx.doi.org/10.1097/01.HS9.0000890988.85828.9b
work_keys_str_mv AT rusconichiara p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT riccifrancesca p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT ziliolivittorior p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT marascovincenzo p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT calabrettaeleonora p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT guidettianna p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT muzicristina p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT mazzonfederico p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT smaniamargherita p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT sollinimartina p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT melierika p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT rodarimarcello p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT ravanoemanuele p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT cairoliroberto p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT corradinipaolo p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles
AT santoroarmando p105decisionalroleofinterimpetinrelapsedrefractoryclassicalhodgkinlymphomatreatedwithfourbegevcycles